HIV Cure Research and The Dual Aims of the Informed Consent Process

Guest Post: Danielle Bromwich and Joseph Millum Paper: Informed Consent to HIV Research  Special Issue: The benefit/risk ratio challenge in clinical research, and the case of HIV cure A cure for HIV would be tremendously valuable. Approximately 37 million people worldwide are HIV-positive and 15 million are currently on antiretroviral therapy. Until recently it was assumed […]

Read More…

A Matter of Life and Death

Guest Post by Professor Lynn Turner-Stokes Re: A matter of life and death – controversy at the interface between clinical and legal decision-making in prolonged disorders of consciousness In an article published in the JME, I highlight the confusion that exists amongst many clinicians, lawyers and members of the public about decisions with withdraw life-sustaining treatments […]

Read More…

Professionalism, or Prying?

“Professionalism” is a funny thing.  About this time last year, I was struggling to get a new course written for the coming semester; it was on professional ethics for lawyers.  A colleague made a comment along the lines that I must be spending a lot of time looking at the professional codes; I replied that […]

Read More…

Randomised Placebo-Controlled Trials of Surgery: Ethical Analysis and Guidelines

Guest Post by Karolina Wartolowska Re: Randomised placebo-controlled trials of surgery: ethical analysis and guidelines [open access] Surgical placebo-controlled randomised controlled trials are, in many ways, like placebo-controlled drug trials. Like in case of drug trials, sometimes, a placebo-controlled design is necessary so that the results are valid and unbiased. Placebo control is usually necessary when a […]

Read More…

No Diagnosis for You, Matey!

Here’s a little amusement for the weekend, from a friend who lives in the States: I received a state of the arts cardio monitor, per a prescription from a cardiologist, to determine if I have an irregular heart beat.  All chrome and aluminium and clean and small with various electronic devices to transmit “information” to […]

Read More…

The Challenge of Futile Treatment

Guest Post by Lindy Willmott and Ben White For decades, researchers from around the world have found evidence that doctors provide futile treatment to adult patients who are dying.  Some discussion of this topic has turned on matters of definition (see our recent contribution to this debate), with a broader concept of “perceived inappropriate treatment” […]

Read More…

Individualised and Personalised QALYs in Exceptional Treatment Decisions

Guest Post by Warwick Heale When NICE decides whether to make a treatment available on the NHS it considers both clinical effectiveness and cost effectiveness.  Cost effectiveness is based on population-level QALY data, as is appropriate for a population-level policy.  However, this can cause problems for exceptional individual patients. When a doctor wants to offer an […]

Read More…

There’s Argument, and there’s Disputation.

Very well, then: let’s allow that the quality of argument in bioethics – and clinical ethics in particular – is not of high quality.  What should be done about it? That’s a hard question, though it’s predictable and wholly justifiable that it should be asked.  And, to be honest, I don’t know offhand.  I might […]

Read More…